KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,102,837 | +9.8% | 65,961 | +38.4% | 0.65% | +24.8% |
| Q2 2023 | $1,915,019 | +131.6% | 47,661 | +146.2% | 0.52% | +111.3% |
| Q1 2023 | $826,715 | -47.8% | 19,361 | -41.3% | 0.25% | -44.4% |
| Q4 2022 | $1,584,660 | +8.0% | 33,000 | -15.4% | 0.45% | +12.9% |
| Q3 2022 | $1,467,000 | +36.1% | 39,000 | 0.0% | 0.40% | +34.4% |
| Q2 2022 | $1,078,000 | – | 39,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |